FDA — authorised 8 June 2012
- Application: BLA125409
- Marketing authorisation holder: GENENTECH
- Status: supplemented
🇺🇸 Perjeta in United States
FDA authorised Perjeta on 8 June 2012
Marketing authorisations
FDA
- Status: approved
Other Oncology approved in United States
Frequently asked questions
Is Perjeta approved in United States?
Yes. FDA authorised it on 8 June 2012; FDA has authorised it.
Who is the marketing authorisation holder for Perjeta in United States?
GENENTECH holds the US marketing authorisation.